1. 上海市长宁区天山路街道社区卫生服务中心,上海,200051
2. 复旦大学附属华东医院心内科,上海,200040
扫 描 看 全 文
毕芳芳, 谈玉婷, 刘千军. 消瘀降脂胶囊对健康受试者肝肾功能影响的临床研究[J]. 上海中医药杂志, 2015,49(6):42-44.
BI Fang-fang, TAN Yu-ting, LIU Qian-jun. Influences of “Xiaoyu Jiangzhi Capsule” on liver and kidney functions in healthy subjects[J]. Shanghai Journal of Traditional Chinese Medicine, 2015,49(6):42-44.
目的:观察消瘀降脂胶囊对健康受试者肝肾功能的影响以寻求安全有效剂量范围 方法:采用多剂量随机开放性研究:①将24名受试者随机分为6个剂量组进行单剂量耐受性试验,分别给予消瘀降脂胶囊250 mg、500 mg、1 000 mg、1250 mg、1 500 mg、2 000 mg;②将10名受试者随机分为2组进行累积剂量耐受性试验,分别给药1 250 mg和1 500 mg,每日2次,连服7天。观察受试者用药前后肝肾功能变化和不良事件情况 结果:受试者用药前后肝肾功能指标均在正常范围内,未出现不良反应 结论:消瘀降脂胶囊在推荐临床用量范围内应用安全。
Objective:To observe the response and tolerance of “Xiaoyu Jiangzhi Capsule” on healthy subjects to explore a safe effective dosage Methods:Randomized, multi-dose and open research was conducted. ①Twenty-four healthy subjects were randomized into six groups by single dosage respectively at 250 mg, 500 mg, 1 000 mg, 1 250 mg, and 1 500 mg; ②Ten healthy subjects were randomized into two groups by accumulative dosage at 1 250 mg and 1 500 mg, twice a day for total 7 days. Some indexes indicating liver and kidney functions were checked before and after administration of “Xiaoyu Jiangzhi Capsule”, and the adverse events were also recorded Results:The indexes indicating liver and kidney functions before and after treatment were at normal ranges, and no adverse events were found during the whole experiment Conclusion:“Xiaoyu Jiangzhi Capsule” is safe in clinical application at its recommended dosage.
消瘀降脂胶囊I期临床试验用药剂量耐受性安全性
“Xiaoyu Jiangzhi Capsule”phase I clinical trialherbal dosagetolerancesafety
0
浏览量
44
下载量
0
CSCD
1
CNKI被引量
关联资源
相关文章
相关作者
相关机构